AI-designed universal vaccine clears first human trial, targets future coronavirus threats with needle-free delivery
medicalxpress.com
The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no significant side effects.
    • Gladaed@feddit.orgEnglish
      0·
      2 days ago

      I am sorry, but did you read that I was talking about medicine first and foremost?

      Also using evidence based approaches can be beneficial for longevity of any company and if you truly believe otherwise, then that’s your perogative.